Literature DB >> 10944185

Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly.

D E Otzen1, O Kristensen, M Oliveberg.   

Abstract

Limited solubility and precipitation of amyloidogenic sequences such as the Alzheimer peptide (beta-AP) are major obstacles to a molecular understanding of protein fibrillation and deposition processes. Here we have circumvented the solubility problem by stepwise engineering a beta-AP homology into a soluble scaffold, the monomeric protein S6. The S6 construct with the highest beta-AP homology crystallizes as a tetramer that is linked by the beta-AP residues forming intermolecular antiparallel beta-sheets. This construct also shows increased coil aggregation during refolding, and a 14-mer peptide encompassing the engineered sequence forms fibrils. Mutational analysis shows that intermolecular association is linked to the overall hydrophobicity of the sticky sequence and implies the existence of "structural gatekeepers" in the wild-type protein, that is, charged side chains that prevent aggregation by interrupting contiguous stretches of hydrophobic residues in the primary sequence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944185      PMCID: PMC27622          DOI: 10.1073/pnas.160086297

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB.

Authors:  M Gross; D K Wilkins; M C Pitkeathly; E W Chung; C Higham; A Clark; C M Dobson
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

Review 2.  Protein misfolding, evolution and disease.

Authors:  C M Dobson
Journal:  Trends Biochem Sci       Date:  1999-09       Impact factor: 13.807

3.  Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

Authors:  M Sunde; L C Serpell; M Bartlam; P E Fraser; M B Pepys; C C Blake
Journal:  J Mol Biol       Date:  1997-10-31       Impact factor: 5.469

Review 4.  Oligomer formation by 3D domain swapping: a model for protein assembly and misassembly.

Authors:  M P Schlunegger; M J Bennett; D Eisenberg
Journal:  Adv Protein Chem       Date:  1997

5.  Nonrandomness in protein sequences: evidence for a physically driven stage of evolution?

Authors:  V S Pande; A Y Grosberg; T Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

7.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

8.  Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.

Authors:  W E Klunk; R F Jacob; R P Mason
Journal:  Anal Biochem       Date:  1999-01-01       Impact factor: 3.365

9.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

10.  Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis.

Authors:  L R Helms; R Wetzel
Journal:  J Mol Biol       Date:  1996-03-22       Impact factor: 5.469

View more
  54 in total

1.  Three-dimensional structure of the lithostathine protofibril, a protein involved in Alzheimer's disease.

Authors:  C Grégoire; S Marco; J Thimonier; L Duplan; E Laurine; J P Chauvin; B Michel; V Peyrot; J M Verdier
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  De novo designed peptide-based amyloid fibrils.

Authors:  Manuela López De La Paz; Kenneth Goldie; Jesús Zurdo; Emmanuel Lacroix; Christopher M Dobson; Andreas Hoenger; Luis Serrano
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

3.  Sequence determinants of amyloid fibril formation.

Authors:  Manuela López de la Paz; Luis Serrano
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

4.  Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case.

Authors:  Salvador Ventura; Jesús Zurdo; Saravanakumar Narayanan; Matilde Parreño; Ramón Mangues; Bernd Reif; Fabrizio Chiti; Elisa Giannoni; Christopher M Dobson; Francesc X Aviles; Luis Serrano
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

5.  Oligomerization of amyloid Abeta16-22 peptides using hydrogen bonds and hydrophobicity forces.

Authors:  Giorgio Favrin; Anders Irbäck; Sandipan Mohanty
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

6.  Transient formation of nano-crystalline structures during fibrillation of an Abeta-like peptide.

Authors:  Daniel E Otzen; Mikael Oliveberg
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

7.  Trimming down a protein structure to its bare foldons: spatial organization of the cooperative unit.

Authors:  Ellinor Haglund; Jens Danielsson; Saraboji Kadhirvel; Magnus O Lindberg; Derek T Logan; Mikael Oliveberg
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

8.  Intrinsic disorder modulates protein self-assembly and aggregation.

Authors:  Alfonso De Simone; Craig Kitchen; Ann H Kwan; Margaret Sunde; Christopher M Dobson; Daan Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

9.  Folding without charges.

Authors:  Martin Kurnik; Linda Hedberg; Jens Danielsson; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-27       Impact factor: 11.205

10.  Functional amyloid: turning swords into plowshares.

Authors:  Daniel Otzen
Journal:  Prion       Date:  2010-10-17       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.